50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Beneficient executive Jeff Welday sells shares worth $2,186

Published 24/12/2024, 10:38 am
BENF
-

Jeff Welday, the Global Head of Organizations and Distribution at Beneficient (NASDAQ:BENF), recently sold 3,364 shares of the company's Class A Common Stock. The transaction, which took place on December 23, 2024, was executed at a price of $0.65 per share, amounting to a total of $2,186. The stock, currently trading at $0.69, has experienced significant volatility, falling nearly 98% year-to-date. According to InvestingPro analysis, BENF is currently trading near its Fair Value. This sale was conducted to cover tax withholding obligations related to the vesting and settlement of restricted stock units (RSUs). Following this transaction, Welday retains ownership of 89,018 shares in the company. InvestingPro data reveals the company faces challenges with cash burn and short-term obligations. Subscribers can access 13 additional ProTips and a comprehensive Pro Research Report for deeper insights into BENF's financial health.

In other recent news, Beneficient Company has announced an agreement to acquire Puerto Rico-based Mercantile Bank (NASDAQ:MBWM) International Corp. for $1.5 million. The acquisition, expected to close in the second quarter of 2025, aims to broaden Beneficient's range of services and client base. In addition, Beneficient has regained compliance with Nasdaq's requirements, ensuring its continued listing on the exchange. The company has also reported sustained growth in Q2 of fiscal 2025, with a net income of $9.7 million, marking its second consecutive quarter of profitability. Beneficient also appointed Karen J. Wendel (EPA:MWDP) to its Board of Directors, whose expertise in banking and cybersecurity is expected to enhance the company's decision-making at the board level. Despite a decline in year-to-date net income and distributions compared to the previous year, Beneficient anticipates growth in demand for liquidity in its target markets. These are among the recent developments for Beneficient.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.